B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats

Neurobiology of Disease

Volumn 25, Issue 3, 2007, Pages 642-648

  Zhu, Wei ^a   Mix, Eilhard ^b   Jin, Tao ^a,c   Adem, Abdu ^d   Zhu, Jie ^a,c  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Antibody; B cell; CD40 CD40L; Co stimulatory molecules; Experimental autoimmune neuritis; Guillain Barr syndrome; Immune response; Inflammation; T cell

Indexed keywords

ANTIBODY; AUTOANTIBODY; CD40 ANTIGEN; CD40 LIGAND; MYELIN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL INTERACTION; CELL LINE; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; LYMPHATIC DRAINAGE; MALE; NEURITIS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; T LYMPHOCYTE; TARGET ORGAN;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL COMMUNICATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MYELIN P0 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; SCIATIC NERVE; T-LYMPHOCYTES;

EID: 33847206484     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.11.010     Document Type: Article

References (33)

1. Adelmann M., and Linington C. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem. Res. 17 (1992) 887-891
2. Armati P.J., and Pollard J.D. Immunology of the Schwann cell. Bailliere's Clin. Neurol. 5 (1996) 47-64
3. Bao L., Lindgren J.U., Meide P., van der Zhu S.W., Ljunggren H.-G., and Zhu J. IL-12 is decisive for initiating, enhancing and perpetuating pathogenic events in murine experimental autoimmune neuritis. Brain Pathol. 12 (2002) 420-429
4. Clark E.A., and Ledbetter J.A. How B and T cells talk to each other. Nature 367 (1994) 425-428
5. Datta S.K., and Kalled S.L. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum. 40 (1997) 1735-1745
6. Deretzi G., Zou L.P., Pelidou H.S., Nennesmo I., Levi M., Wahren B., Mix E., and Zhu J. Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination. J. Autoimmun. 12 (1999) 81-89
7. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541-543
8. Filion L.G., Matusevicius D., Graziani-Bowering G.M., Kumar A., and Freedman M.S. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis. Clin. Immunol. 106 (2003) 127-138
9. Goules A., Tzioufas A.G., Manousakis M.N., Kirou K.A., Crow M.K., and Routsias J.G. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J. Autoimmun. 26 (2006) 165-171
10. Grewal I.S., and Flavell R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153 (1996) 85-106
11. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16 (1998) 111-135
12. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway Jr. C.A., and Flavell R.A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273 (1996) 1864-1867
13. Hays A.P., Latov N., Takatsu M., and Sherman W.H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37 (1987) 242-256
14. Hughes R.A. Plasmahange versus intravenous immunoglobulin for Guillain-Barre syndrome. Ther. Apher. 1 (1997) 129-130
15. Hughes R.A.C., Powell H.C., Braheny S.L., and Brostoff S.W. Endoneurial infection of antisera to myelin antigens. Muscle Nerve 8 (1985) 516-522
16. Hughes R.A., Hadden R.D., Gregson N.A., and Smith K.J. Pathogenesis of Guillain-Barre syndrome. J. Neuroimmunol. 100 (1999) 74-97
17. Ina Y., and Sakai K. Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: analysis of immune cell populations and surface molecules. Int. J. Radiat. Biol. 81 (2005) 721-729
18. Karupiah G., Sacks T.E., Klinman D.M., Fredrickson T.N., Hartley J.W., Chen J.H., and Morse H.C. Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. Virology 240 (1998) 12-26
19. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., and Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 44 (1998) 202-208
20. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., and Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22 (1992) 2573-2578
21. Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol. Rev. 99 (1987) 39-51
22. Norton W.I., and Poduslo S.E. Myelination in rat nerve: method of myelin isolation. J. Neurochem. 21 (1973) 749-757
23. Notarangelo L.D., and Peitsch M.C. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol. Today 17 (1996) 511-516
24. Otterdal K., Pedersen T.M., and Solum N.O. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase. Thromb. Res. 114 (2004) 167-177
25. Press R., Mata S., Lolli F., Zhu J., Andersson T., and Link H. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. J. Neurol. Sci. 190 (2001) 41-47
26. Rodriguez-Pinto D., and Moreno J. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur. J. Immunol. 35 (2005) 1097-1105
27. Wang C.R., and Liu M.F. Regulation of CCR5 expression and MIP-1alpha production in CD4+ T cells from patients with rheumatoid arthritis. Clin. Exp. Immunol. 132 (2003) 371-378
28. Williams R.M., Krakowka S., and Koestner A. In vivo demyelination by antimyelin antibodies. Acta Neuropathol. 50 (1980) 1-8
29. Zhu J., Link H., Weerth S., Linington C., Mix E., and Qiao J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J. Neurol. Sci. 125 (1994) 132-137
30. Zhu J., Bai X.F., Mix E., and Link H. Cytokine dichotomy in the peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1β, IL-6, IL-10, IL-12, TNF-α and TNF-β and cytolysin. Clin. Immunol. Immunopathol. 84 (1997) 85-94
31. Zhu J., Bai X.F., Mix E., and Link H. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J. Neuroimmunol. 78 (1997) 108-116
32. Zhu J., Mix E., and Link H. Cytokine production and the pathogenesis of experimental allergic neuritis and Guillain-Barré syndrome. J. Neuroimmunol. 84 (1998) 40-52
33. Zhu Y., Ljunggren H.G., Mix E., Li H.L., Meide P., van der Elhassan A.M., Winblad B., and Zhu J. Suppression of autoimmune neuritis in IFN-γ receptor-deficient mice. Exp. Neurol. 169 (2001) 472-478